Cargando…
Effectiveness and Tolerability of Different Recommended Doses of PPIs and H(2)RAs in GERD: Network Meta-Analysis and GRADE system
Proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H(2)RAs) are used for gastro-esophageal reflux disease (GERD); however, the clinical evidence for treatment is poor. We evaluated the effectiveness and tolerability of different doses of PPIs, H(2)RAs and placebo in adults with GERD...
Autores principales: | Zhang, Chao, Kwong, Joey S. W., Yuan, Rui-Xia, Chen, Hao, Xu, Chang, Wang, Yi-Pin, Yang, Gong-Li, Yan, Jin-Zhu, Peng, Le, Zeng, Xian-Tao, Weng, Hong, Luo, Jie, Niu, Yu-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244481/ https://www.ncbi.nlm.nih.gov/pubmed/28102361 http://dx.doi.org/10.1038/srep41021 |
Ejemplares similares
-
Impact of PPIs on patient focused symptomatology in GERD
por: Thomson, ABR
Publicado: (2008) -
Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2023) -
PPIs and gastric cancer: any causal relationship?
por: Crafa, Pellegrino, et al.
Publicado: (2023) -
Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
por: Liu, Junyuan, et al.
Publicado: (2020) -
Current status of acid pump antagonists (reversible PPIs).
por: Wurst, W., et al.
Publicado: (1996)